Benchling AI debuts alongside major new capabilities for antibody discovery, automated data analysis, and development BOSTON, Oct. 14, 2025 /PRNewswire/ -- Benchling today unveiled major new ...

SAN FRANCISCO and BOSTON, May 7, 2025 /PRNewswire/ -- Benchling, the R&D platform powering the biotech industry, today announced an expanded collaboration with Moderna. What began with Benchling ...

Antibody R&D teams can configure any format in minutes and register up to 1,000 antibodies in a single run Benchling Biologics is the end-to-end platform for antibody R&D, giving teams the AI-ready ...

After the last two decades of consumer Internet and mobile innovation, is biotech or bioinformatics the next wave? There are a handful of San Francisco-based startups that cross the bridge between the ...

Investors are eager for the Benchling IPO. The company made headlines when it confidentially filed with the SEC to go public. Biotechnology is rewriting life as we know it. Our customers, spanning ...

Antibody R&D teams can configure any format in minutes and register up to 1,000 antibodies in a single run "Most R&D systems can't represent the antibody formats teams are actually working with," said ...